Building on our experience in executive and senior technical leadership roles in preclinical and clinical drug development, and our extensive network of consulting and pharmaceutical services partnerships, we offer solutions to today’s challenges in biomarker translational research and biomarker-based strategies for risk assessment, proof-of-concept, personalized medicine and companion diagnostics development.

 We specialize in helping biopharmaceutical sponsors and service providers build mutually profitable and virtual translational research models in today’s resource-constrained, dynamic environment that address specific portfolio and unmet customer needs through organizational effectiveness, enabling technologies, partnership development and sourcing strategies.